The CSF3R T618I mutation as a disease-specific marker of atypical CML post allo-SCT
S E Langabeer1, S L McCarron1, K Haslam1
1Cancer Molecular Diagnostics, St James's Hospital, Dublin 8, Ireland.
Bone Marrow Transplantation
|March 12, 2014
Abstract
No abstract available in PubMed .


